WO2009001884A1 - Comprimé de glutathion oxydé - Google Patents

Comprimé de glutathion oxydé Download PDF

Info

Publication number
WO2009001884A1
WO2009001884A1 PCT/JP2008/061611 JP2008061611W WO2009001884A1 WO 2009001884 A1 WO2009001884 A1 WO 2009001884A1 JP 2008061611 W JP2008061611 W JP 2008061611W WO 2009001884 A1 WO2009001884 A1 WO 2009001884A1
Authority
WO
WIPO (PCT)
Prior art keywords
tablet
oxidized glutathione
disclosed
containing oxidized
tablet containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/061611
Other languages
English (en)
Japanese (ja)
Inventor
Yuichiro Nakano
Yasushi Sakai
Tsuyoshi Shimose
Takeshi Shibasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Hakko Bio Co Ltd
Original Assignee
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co Ltd filed Critical Kyowa Hakko Bio Co Ltd
Publication of WO2009001884A1 publication Critical patent/WO2009001884A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un comprimé renfermant du glutathion oxydé présentant une dureté de comprimé suffisante. L'invention a également pour objet un procédé de production aisée d'un comprimé renfermant du glutathion oxydé.
PCT/JP2008/061611 2007-06-26 2008-06-26 Comprimé de glutathion oxydé Ceased WO2009001884A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-167195 2007-06-26
JP2007167195 2007-06-26

Publications (1)

Publication Number Publication Date
WO2009001884A1 true WO2009001884A1 (fr) 2008-12-31

Family

ID=40185696

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/061611 Ceased WO2009001884A1 (fr) 2007-06-26 2008-06-26 Comprimé de glutathion oxydé

Country Status (1)

Country Link
WO (1) WO2009001884A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012063973A1 (fr) * 2010-11-11 2012-05-18 Kyowa Hakko Bio Co., Ltd. Composition antioxydante comprenant du glutathion oxydé
WO2014051168A1 (fr) * 2012-09-28 2014-04-03 Kyowa Hakko Bio Co., Ltd. Agent d'amélioration de l'immunité contenant du glutathion
US9308234B2 (en) 2012-10-29 2016-04-12 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US11497786B2 (en) 2017-11-17 2022-11-15 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
US11602555B2 (en) 2016-11-17 2023-03-14 Renovion, Inc. Treatment of respiratory tract diseases and infections with ascorbic acid compositions
US12097238B2 (en) 2022-01-04 2024-09-24 Renovion, Inc. Aqueous solution comprising a glutathione salt

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453368A (en) * 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
WO2003035674A1 (fr) * 2001-10-25 2003-05-01 Kyowa Hakko Kogyo Co., Ltd. Cristal de glutathione oxydee et son procede de production
JP2005104972A (ja) * 2003-09-08 2005-04-21 Nof Corp Ｌ−カルニチン圧縮成形体、及びその製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453368A (en) * 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
WO2003035674A1 (fr) * 2001-10-25 2003-05-01 Kyowa Hakko Kogyo Co., Ltd. Cristal de glutathione oxydee et son procede de production
JP2005104972A (ja) * 2003-09-08 2005-04-21 Nof Corp Ｌ−カルニチン圧縮成形体、及びその製造方法

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012063973A1 (fr) * 2010-11-11 2012-05-18 Kyowa Hakko Bio Co., Ltd. Composition antioxydante comprenant du glutathion oxydé
WO2014051168A1 (fr) * 2012-09-28 2014-04-03 Kyowa Hakko Bio Co., Ltd. Agent d'amélioration de l'immunité contenant du glutathion
US9308234B2 (en) 2012-10-29 2016-04-12 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US10406200B2 (en) 2012-10-29 2019-09-10 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucusal tissue disorders
US11058743B2 (en) 2012-10-29 2021-07-13 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US11938166B2 (en) 2012-10-29 2024-03-26 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US11602555B2 (en) 2016-11-17 2023-03-14 Renovion, Inc. Treatment of respiratory tract diseases and infections with ascorbic acid compositions
US12427180B2 (en) 2016-11-17 2025-09-30 Renovion, Inc. Treatment of respiratory tract diseases and infections with ascorbic acid compositions
US11890315B2 (en) 2017-11-17 2024-02-06 Renovion, Inc. Stable ascorbic acid compositions and methods of using same
US11497786B2 (en) 2017-11-17 2022-11-15 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
US12350307B2 (en) 2017-11-17 2025-07-08 Renovion, Inc. Stable ascorbic acid compositions and methods of using same
US12097238B2 (en) 2022-01-04 2024-09-24 Renovion, Inc. Aqueous solution comprising a glutathione salt
US12419932B2 (en) 2022-01-04 2025-09-23 Renovion, Inc. Aqueous solution comprising a glutathione salt

Similar Documents

Publication Publication Date Title
EG25254A (en) A method of producing titanium.
WO2006033720A3 (fr) Procede d'expansion
PL2079308T3 (pl) Sposób zapobiegania rozwojowi mikroorganizmów oraz kombinacja do zapobiegania rozwojowi mikroorganizmów
WO2009001884A1 (fr) Comprimé de glutathion oxydé
WO2008014084A3 (fr) Pipeline
GB0417881D0 (en) Process for the enzymatic oxidation of a substrate comprising a primary hydroxyl group
WO2007143065A3 (fr) Procédé de synthèse de duloxétine et de ses intermédiaires
WO2007009887A3 (fr) Preparation contenant du sulfate de baryum
GB0604275D0 (en) A method of reducing D.C. offset
WO2008125989A3 (fr) Nouvel inhibiteur du protéasome
WO2006089651A3 (fr) Comprimes pelliculaires a base de trofosfamide et procede permettant de les produire
GB0503650D0 (en) Method of generating a pressure differential
AU2006903183A0 (en) A retainer
AU2004902854A0 (en) Metallo-polypeptide analgesic production method
EM05519730007S (fr) Clés [clefs] [serrurerie]; Clés vierges
EM05519730005S (fr) Clés [clefs] [serrurerie]; Clés vierges
EM05519730003S (fr) Clés vierges; Clés [clefs] [serrurerie]
EM05519730001S (fr) Clés vierges; Clés [clefs] [serrurerie]
AU2005905080A0 (en) A method of treatment - II
AU2005902047A0 (en) A method of differentiation-II
AU2006905988A0 (en) Information Templating Method
AU2006901416A0 (en) Sequestering carbon dioxide
AU2004901902A0 (en) A method of providing finance
AU2005901632A0 (en) Method for transforming text into a visual form
AU2005902549A0 (en) Method of operating a roll-former

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08790626

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08790626

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP